iRhythm Technologies, Inc.

NASDAQ:IRTC

Medical - Devices

Healthcare
$94.87 +0.35%

+$0.36 today

Market cap
$3.19B
Beta
1.28
P/E (TTM)
-119.5
EPS (TTM)
-$0.85
52W Low $100.85High $212.00

Volume 1.20M

Average 0.52M

IRTC Stock-Based Compensation

Employee pay granted in shares or options; a non-cash expense that dilutes existing shareholders.

iRhythm Technologies, Inc.NASDAQ: IRTC

Stock-Based Compensation · Q3 FY2026 · quarter ended Sep 2026

Stock-based compensation declines year over year

Q3 FY2026 stock-based compensation of $19.49M fell 7.2% year over year, behind the -1.3% change in trailing-twelve-month stock-based compensation. Sequentially, it fell 2.7% from the prior quarter. Over 3 fiscal years it compounded at +15.2% a year.

Context

  • Stock-based compensation amounted to 11.8% of revenue in FY2025, down 1.0 pp from a year earlier.
  • Stock-based compensation increased in 2 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth recovers from -7.2% toward the trailing-twelve-month pace of -1.3%.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterSep 2026
$19.49M-2.7% QoQ
Last fiscal yearDec 2025
$88.28M+16.2% YoY
LTMSep 2026
$82.13M-1.3% YoY
Stock-Based Compensation past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-7.2%——
1 year+16.2%——
3-year CAGR+15.2%——
5-year CAGR——
10-year CAGR——

Stock-Based Compensation history

USD · from the cash flow

Latest · FY2025
88.28M USD
Year-over-year change
+16.2%
4-year CAGR
+12.8%

Stock-Based Compensation vs competitors

How IRTC compares with its peers on the latest reported figures

  • IRTC's LTM Sep 2026 stock-based compensation of $82.13M is the 3rd largest of the 7 companies compared; the peer median is $54.27M.
  • Its year-over-year change of -1.3% is the lowest of 7, against a peer median of +15.7%.
  • Stock-based compensation amounts to 9.6% of revenue for IRTC, versus a peer median of 3.6%.
IRTC Competitors Peer median
Stock-Based Compensation for IRTC and competitors
Company Period LTM YoY 3-year CAGR% of revenue
MDTMedtronic plcLTM Jul 2026$496M +14.8%+8.8%1.3%
BSXBoston Scientific CorporationLTM Jun 2026$166M +5.7%+10.8%0.8%
IRTCiRhythm Technologies, Inc.LTM Sep 2026$82.13M -1.3%+15.2%9.6%
PENPenumbra, Inc.LTM Jun 2026$59.5M +16.5%—4.0%
LIVNLivaNova PLCLTM Sep 2026$49.04M +44.9%-6.8%3.3%
ATRCAtriCure, Inc.LTM Jun 2026$47.27M +13.2%+15.8%8.3%
KMTSKestra Medical Technologies, Ltd.LTM Jan 2026$45.65M +1845.1%—54.5%
Peer median (excluding IRTC) $54.27M+15.7%+9.8%3.6%

Competitors are the stored peer set for IRTC. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income(101.36M)(116.16M)(123.41M)(113.29M)(44.55M)
Depreciation & Amortization16.59M19.61M22.14M25.78M26.48M
Deferred Income Tax00000
Stock-Based Compensation54.53M57.74M77.2M75.98M88.28M
Change in Working Capital(46.23M)(65.51M)(102.05M)(99.12M)(91.7M)
Accounts Receivables(53.57M)(61.84M)(81.19M)(91.92M)(95.43M)
Inventory(4.96M)(5.11M)979K(224K)(8.51M)
Accounts Payables6.14M(2.99M)(1.97M)028.04M
Other Working Capital6.17M4.43M(19.86M)(6.97M)(15.8M)
Other Non-Cash Items38.72M81.3M76M114.04M102.35M
Operating Cash Flow(37.75M)(23.01M)(50.1M)3.39M80.86M
Capital Expenditures(28.07M)(29.83M)(40.42M)(48.94M)(46.34M)
Acquisitions (Net)00000
Purchases of Investments(122.18M)(188.57M)(167.29M)(175.24M)(468.41M)
Sales of Investments255.52M165.97M206.5M101.2M237.7M
Other Investing Activities000(15M)0
Investing Cash Flow105.26M(52.43M)(1.21M)(122.98M)(277.06M)
Debt Repayment(11.67M)13.53M0619.84M0
Common Stock Issued8.94M008.47M12.61M
Common Stock Repurchased000(25M)0
Dividends Paid00000
Other Financing Activities(25.85M)13.18M8.82M(91.93M)0
Financing Cash Flow(28.58M)26.72M8.82M511.38M12.61M
Effect of Forex Changes00(169K)(6K)1K
Net Change in Cash38.93M(48.73M)(42.66M)391.78M(183.59M)
Free Cash Flow(65.82M)(52.84M)(90.53M)(45.55M)34.52M

iRhythm Technologies, Inc.

NASDAQ:IRTC

Intrinsic Alpha fair value

Locked

Current Price

$94.87

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.